Clinical trial
Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic…
NCT00020644 · Advocate Lutheran General Hospital, Other · Unknown status
Key facts
| NCT number | NCT00020644 |
|---|---|
| Title | Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer |
| Official title | Phase I Study of Continuous Infusion Gemcitabine |
| Lead sponsor | Advocate Lutheran General Hospital, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | gemcitabine hydrochloride |
| Start date | Mar 1, 2000 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 7, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: